Add like
Add dislike
Add to saved papers

Cross-talk between PI3K/Akt and MEK/ERK pathways mediates endoplasmic reticulum stress-induced cell cycle progression and cell death in human hepatocellular carcinoma cells.

The unfolded protein response (UPR) is a conserved adaptive response utilized by cells to cope with endoplasmic reticulum (ER) stress. In addition to the UPR, cells also trigger other adaptive responses under ER stress conditions. Although the PI3K/Akt and MEK/ERK pathways are known to protect cells from ER stress-induced apoptosis, their other functions under ER stress remain elusive. Here, we showed that long-term ER stress resulted in inactivation of Akt and activation of ERK in human hepatocellular carcinoma (HCC) cells. Importantly, both PI3K inhibitor LY294002 and dominant-negative Akt construct promoted tunicamycin- and thapsigargin-induced ERK phosphorylation. In addition, constitutively active Akt construct inhibited ER stress-induced ERK phosphorylation. We also showed that ER stress-induced PI3K/Akt inactivation contributed to cell cycle arrest and MEK/ERK inhibition moderately increased cell percentage in the S phase. It is notable that U0126 made HCC cells much more sensitive to ER stress-induced apoptosis than LY294002. Taken together, our results indicate that there is cross-talk between the PI3K/Akt and MEK/ERK cascades under ER stress in HCC cells, which contributes to both cell cycle arrest and cell survival. We propose that ER stress-induced cross-talk between the PI3K/Akt and MEK/ERK cascades is a protective mechanism utilized by HCC cells to adapt to stress.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app